An interventional study of Magnesium citrate and Placebo in Effect of Magnesium in Diabetes, sponsored by Protina Pharmazeutische GmbH. Completed at 1 site in Germany. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-08-28.
Sponsored by Protina Pharmazeutische GmbH · Not applicable, Interventional, and Treatment
This study aims to determine how a 12-week magnesium supplementation with 400 mg magnesium from organic magnesium citrate affects blood glucose control and insulin resistance within patients with type 2 diabetes (HbA1c> 6%) and how the expression of certain Mg-sensitive transporting genes is affected .
The examinations are carried out in 50 subjects aged 20-80 years with existing type 2 diabetes (HbA1c> 6%). The target parameters are determined in the blood. Blood sampling takes place at confinement, after 6 weeks and at the end of the study (week 12). In addition, blood pressure is determined and general health condition of each subject is recorded by a standardized questionnaire (SF-36).
9,589 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.
This study's enrollment of 50 is below the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Protina Pharmazeutische GmbH is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
identically tasting and looking Placebo
Dietary Supplement: Placebo
Supplementation with 400 mg Magnesium from Magnesium citrate once daily
Dietary Supplement: Magnesium citrate
blood sampling
measurement of type II Diabetes relevant Parameters including Glucose, HbA1c, HOMA-IR, magnesium-sensitive gene expression
Time frame: 12 weeks
blood pressure measurement
measurement of blood pressure
Time frame: 12 weeks
questionnaire SF-36
questionnaire is used to assess the physiological health Status of patients
Time frame: 12 weeks
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Magnesium citrate
Protina Pharmazeutische GmbH